These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7941537)

  • 41. Hormonal therapies for endometriosis: implications for bone metabolism.
    Dawood MY
    Acta Obstet Gynecol Scand Suppl; 1994; 159():22-34. PubMed ID: 8209669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of oral contraceptives on migraine.
    Whitty CW; Hockaday JM; Whitty MM
    Lancet; 1966 Apr; 1(7442):856-9. PubMed ID: 4159965
    [No Abstract]   [Full Text] [Related]  

  • 43. Oral contraceptives and blood-iron.
    Zilva JF
    Lancet; 1969 Oct; 2(7625):847. PubMed ID: 4186302
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current treatment of dysmenorrhea].
    Schurz AR
    Ther Umsch; 1973 Jul; 30(7):511-5. PubMed ID: 4731097
    [No Abstract]   [Full Text] [Related]  

  • 45. Is a statin a statin?
    Wierzbicki AS
    Int J Clin Pract; 2001 Mar; 55(2):79-80. PubMed ID: 11321864
    [No Abstract]   [Full Text] [Related]  

  • 46. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hormonal influence on tubal function].
    Münker G
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1972; 202(2):677-81. PubMed ID: 4646158
    [No Abstract]   [Full Text] [Related]  

  • 48. Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL.
    van den Akker JM; Bredie SJ; Diepenveen SH; van Tits LJ; Stalenhoef AF; van Leusen R
    J Nephrol; 2003; 16(2):238-44. PubMed ID: 12768071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myomas and reproductive function.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2004 Sep; 82 Suppl 1():S111-6. PubMed ID: 15363705
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of oral contraceptives on total-body potassium.
    Flynn MA; Coffman W; Hall D
    Arch Environ Health; 1968 Dec; 17(6):848-9. PubMed ID: 5699292
    [No Abstract]   [Full Text] [Related]  

  • 51. Medical treatment of endometriosis.
    Simón C; García-Velasco J
    Gynecol Obstet Invest; 2004; 57(1):51-2. PubMed ID: 14974458
    [No Abstract]   [Full Text] [Related]  

  • 52. [Apropos of gestagens].
    Coronel L; Rojas G; Contreras R
    Rev Chil Obstet Ginecol; 1965; 30(5):311-24. PubMed ID: 5878760
    [No Abstract]   [Full Text] [Related]  

  • 53. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Changes of the ovarian and uterine blood vessels following administration of progestational substances].
    ten Berge BS
    Arch Gynakol; 1969; 207(1):52-3. PubMed ID: 5819980
    [No Abstract]   [Full Text] [Related]  

  • 57. [The use of oral ovulation-inhibitor hormones. Preliminary report].
    Bergher de Bacalao E; Merchán López D
    Rev Obstet Ginecol Venez; 1966; 26(3):541-50. PubMed ID: 5986948
    [No Abstract]   [Full Text] [Related]  

  • 58. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.